A scoping review of real-world data sources for retrospective oncology analysis in Japan.

D Ng¹, H Pittell², I Nasu¹, M Araki¹, Q Zhang², E Tajima¹, A Sujenthiran³, B Adamson²

¹Flatiron Health K.K., Tokyo Japan.

²Flatiron Health, New York, USA.

³Flatiron Health UK, London, UK.

PubMed PMC DOI PDF

Abstract

BACKGROUND: Cancer remains the leading cause of mortality in Japan, creating significant demand for high-quality real-world evidence to support clinical research and decision making. This study aims to provide a comprehensive overview of oncology studies using real-world data (RWD) in Japan, assessing the suitability of these data sources for oncology research. METHODS: Searches were conducted in…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.